Development and Characterization of PCL Electrospun Membrane-Coated Bletilla striata Polysaccharide-Based Gastroretentive Drug Delivery System
Development and Characterization of PCL Electrospun Membrane-Coated Bletilla striata Polysaccharide-Based Gastroretentive Drug Delivery System
复制标题
PCL电纺膜包被白及多糖胃滞留给药系统的开发和表征
DOI:
10.1208/s12249-019-1607-5
复制
发表时间:
2020-01
影响因子:
3.3
通讯作者:
Qu Yan
中科院分区:
文献类型:
--
作者:
Li Zhouying;Zeng Rui;Yang Ling;Ren Xiaodong;Maffucci Katherine G;Qu Yan
The purpose of this study was to investigate the potential of Bletilla striata polysaccharide (BSP, a natural glucomannan material) for the development of a gastroretentive drug delivery system for the first time. Novel BSP-based porous wafer was prepared for levofloxacin hydrochloride (LFH) delivery by combining floating, swelling, and mucoadhesion mechanisms. The influences of BSP and ethyl cellulose (EC) on drug release and mucoadhesive strength were studied by 32 factorial design. The optimized matrix was coated with polycaprolactone (PCL) electrospun membrane by electrospinning and heat treatment technology. The optimized formula (F6, coated) exhibited Q4 h of 41.20 ± 1.90%, Q8 h of 76.49 ± 1.69%, and mucoadhesive strength of 86.11 ± 1.33 gf, and its drug release profile most closely resembled the Korsmeyer–Peppas model with anomalous diffusion driving mechanism. F6 (coated) also presented excellent buoyancy, preferred swelling characteristic due to the porous structure formed by freeze-drying. Meanwhile, the internal morphology, physical state, drug–excipient compatibility, and thermal behavior were recorded. The negligible cytotoxicity of F6 (coated) was observed in human gastric epithelial cell cultures. In the in vitro antimicrobial experiment, the prepared wafer exhibited obvious bacterial inhibition zone, and due to its longer gastric retention, the wafer also performed a more effective Helicobacter pylori clearance than free LFH in vivo. Graphical abstract Graphical abstract
登录
查看更多内容
DOI:
10.1155/2015/865986
发表时间:
2015
期刊:
Evidence-based complementary and alternative medicine : eCAM
影响因子:
--
作者:
Xuan M;Okazaki M;Iwata N;Asano S;Kamiuchi S;Matsuzaki H;Sakamoto T;Miyano Y;Iizuka H;Hibino Y
通讯作者:
Hibino Y
影响因子:
4.4
作者:
Antos, D;Schneider-Brachert, W;Bayerdörffer, E
通讯作者:
Bayerdörffer, E
影响因子:
4.6
作者:
Azevedo RSS;de Sousa JR;Araujo MTF;Martins Filho AJ;de Alcantara BN;Araujo FMC;Queiroz MGL;Cruz ACR;Vasconcelos BHB;Chiang JO;Martins LC;Casseb LMN;da Silva EV;Carvalho VL;Vasconcelos BCB;Rodrigues SG;Oliveira CS;Quaresma JAS;Vasconcelos PFC
通讯作者:
Vasconcelos PFC
影响因子:
9.9
作者:
G. A. Islan;M. Cacicedo;V. Bosio;Guillermo R. Castro
通讯作者:
G. A. Islan;M. Cacicedo;V. Bosio;Guillermo R. Castro
影响因子:
5.8
作者:
Qi, Xiaole;Chen, Haiyan;Wu, Zhenghong
通讯作者:
Wu, Zhenghong